Table 1.
Patient no. | Gender | Age at presentation | Infective focus | VA at presentation | VA at latest visit | Microorganism |
---|---|---|---|---|---|---|
1 | Male | 38 | Liver | HM | NLP | Klebsiella pneumoniae |
2 | Male | 71 | Liver | NLP | Eviscerated | Klebsiella pneumoniae |
3 | Female | 43 | Nasopharynx | FC | Eviscerated | Staph. aureus + Strep. pneumoniae |
4 | Female | 58 | Liver | FC | 20/200 | Klebsiella pneumoniae |
5 | Female | 75 | Urinary tract | HM | NLP | Escherichia coli |
6 | Male | 89 | Pulmonary | 20/1200 | Eviscerated | Strep. pneumoniae |
7 | Male | 51 | Central nervous system | FC | N/A | Candida sp. |
8 | Male | 42 | Brain | FC | NLP | Candida sp. |
9 | Male | 41 | Liver | LP | NLP | Klebsiella pneumoniae |
10 | Female | 67 | Necrotizing fasciitis | HM | NLP | Strep. Pyogenes |
11 | Male | 70 | Nil | 20/1200 | NLP | Aspergillus sp. |
12 | Male | 55 | Intravenous drug | HM | 20/400 | Staph. Aureus |
13 | Female | 75 | Urinary tract | LP | NLP | Klebsiella pneumonia |
14a | Female | 60 | Urinary tract | FC | 20/320 | Candida sp. |
14b | 20/800 | NLP | Candida sp. | |||
15 | Female | 65 | Nil | LP | Eviscerated | Klebsiella pneumonia |
16 | Female | 58 | Urinary tract | HM | Eviscerated | Escherichia coli |
17 | Male | 65 | Urinary tract | HM | NLP | Candida sp. |
18 | Male | 76 | Nil | NLP | Eviscerated | Klebsiella pneumoniae |
19 | Female | 58 | Knee | HM | NLP | Strep. agalactiae |
20 | Female | 86 | Urinary tract | HM | 20/100 | Klebsiella pneumonia |
21 | Male | 56 | Back abscess | 20/400 | 20/200 | Enterobacter sp. |
FC: finger counting; HM: hand motion; LP: light perception; NLP: no light perception.